The Nanosonics Story

Nanosonics is leading the way with innovative solutions focused on preventing the transmission of life-altering infections.

Nanosonics is an Australian infection prevention company that has successfully developed and commercialised a unique automated disinfection technology, trophon®, representing the first major innovation in high level disinfection for ultrasound probes in more than 20 years. trophon is fast becoming the global standard of care for ultrasound probe disinfection.

Preventable infections are exactly that - preventable. But many medical institutions are forced to spend time and resources dealing with outbreaks of preventable infections. These infections diminish a patient's quality of care and undermine a healthcare professional's capacity to provide this care.

For this reason Nanosonics constantly pursues breakthrough innovations with the potential to transform infection prevention. Our vision is to provide fail-safe infection prevention solutions that protect not only an institution's quality of care, but more importantly the lives of those they treat.

So we pioneer ground-breaking technologies to prevent life-altering infections. We set new standards that redefine best practice. And we strive to be a global leader in infection prevention innovation.

OUR MISSION: We improve the safety of patients, clinics, their staff and the environment by transforming the way infection prevention practices are understood and conducted, and introducing innovative technologies that deliver improved standards of care.

Our Core Values


Our 5 Areas Of Focus


Company Timeline

FOUNDED IN 2001 and head-quartered in Sydney, Australia, Nanosonics listed on the Australian Securities Exchange (NAN) in 2007.

Nanosonics lists on the Australian Securities Exchange (NAN) in 2007.

IN 2009, we launched trophon, our unique, automated technology for the HLD of intracavity and surface ultrasound probes.

IN MARCH 2015, Nanosonics was included in the Australian Stock Exchange ASX300 Index (Australia’s top 300 companies by market capitalisation). 

The company joined the Australian Stock Exchange ASX200 Index (Australia’s top 200 companies by market capitalisation).

IN AUGUST 2018, Nanosonics launched trophon®2, the latest innovation in ultrasound probe high level disinfection. We also launched trophon® Companion Wipes, the perfect partner to streamline ultrasound probe reprocessing.

TODAY we have offices in North America, Canada, the United Kingdom and Europe, employing more than 200 people.


Our Global Presence

Next
Careers
;